A single‐centre result of two courses of low‐intensity shockwave therapy (Li‐SWT) in erectile dysfunction

• Published in: Andrologia Vol. 54; no. 2; pp. e14324 - n/a
• Main Author: Geyik, Serdar
• Format: Journal Article
• Language: English
• Published: Germany Wiley Subscription Services, Inc 01.03.2022
• Subjects: Adult; Diabetes; Diabetes mellitus; Erectile dysfunction; Erectile Dysfunction - therapy; Extracorporeal Shockwave Therapy; High-Energy Shock Waves; Humans; Male; Middle Aged; Patients; Penile Erection; Retrospective Studies; Statistical analysis; two courses of low‐intensity shockwave therapy; two courses of low-intensity shockwave therapy; diabetes mellitus; erectile dysfunction
• ISSN: 0303-4569; 1439-0272
• DOI: 10.1111/and.14324

The purpose of this study is to evaluate the results of two courses of low‐intensity shock wave therapy (Li‐SWT) in the treatment of patients with erectile dysfunction (ED). Between June 2015 and December 2020, diabetic and non‐diabetic patients with ED treated with two Li‐SWT courses were evaluated retrospectively among the data of 317 patients. The outcomes were evaluated using the International Index of Erectile Function‐Erectile Function Domain (IIEF‐EF) questionnaire values at baseline and 6 months post‐treatment for each Li‐SWT course with (0.09 mJ/mm²) 18000 shock waves. Successful treatment criteria for patients who also underwent physical examination and anamnesis before and after each course were IIEF‐EF scores≥26 during the 6 months follow‐up. Forty‐one patients with a mean age of 51.61 ± 11.80 years were included in the study. The mean IIEF‐EF scores were 15.17 ± 3.75 at baseline, 21.61 ± 3.60 after the first course [mean difference(MD): −6.439; 95%, confidence interval(CI), −7.138: −5.740; t = −18.621; p < 0.001], and 25.27 ± 4.05 after the second course(MD: −3.658; 95% CI, −4,067: −3.249; t = −18,071; p < 0.001). Evaluation of score increases in diabetic patients was also statistically significant for each course (p < 0.001). Our study shows that two courses of Li‐SWT treatments are safe for both diabetic and non‐diabetic patients with ED and effective for each course.